featured
FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular Dystrophy
Approval of deflazacort oral suspension is for patients 5 years of age and older
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.